Zydus Wellness Limited (NSE:ZYDUSWELL)

India · Delayed Price · Currency is INR

467.35

-2.05 (-0.44%)

Nov 11, 2026, 12:50 PM IST

Market Cap	148.44B +3.7%
Revenue (ttm)	50.13B +73.7%
Net Income	2.46B -2.9%
EPS	7.74 -2.8%
Shares Out	n/a
PE Ratio	60.39
Forward PE	38.30
Dividend	1.20 (0.26%)
Ex-Dividend Date	Jul 17, 2026

Volume	99,626
Open	474.00
Previous Close	469.40
Day's Range	466.50 - 474.95
52-Week Range	367.55 - 611.85
Beta	-0.06
Analysts	Strong Buy
Price Target	582.63 (+24.67%)
Earnings Date	Nov 3, 2026

About Zydus Wellness

Zydus Wellness Limited engages in the development, production, marketing, and distribution of health and wellness products in Asia, the Middle East, Africa, the Oceania, Europe, and North America. It provides glucose powder under the Glucon-D brand; sugar substitute products under the Sugar Free Gold+, Sugar Free Natura, Sugar Free Green, and I'm lite brands; Milk-based nutrition drink products under the Complan brand; table spreads under the Nutralite brand; skin cleansing products under the Everyuth brand; hair color products under the Cutico... [Read more]

Industry Packaged Foods

Sector Consumer Staples

Founded 1988

Employees 1,685

Stock Exchange National Stock Exchange of India

Ticker Symbol ZYDUSWELL

Full Company Profile

Financial Performance

In fiscal year 2026, Zydus Wellness's revenue was 39.61 billion, an increase of 46.22% compared to the previous year's 27.09 billion. Earnings were 1.97 billion, a decrease of -43.15%.

Financial Statements

Analyst Summary

According to 8 analysts, the average rating for ZYDUSWELL stock is "Strong Buy." The 12-month stock price target is ₹582.63, which is an increase of 24.67% from the latest price.

Price Target

₹582.63

(24.67% upside)

Analyst Consensus: Strong Buy

Stock Forecasts

News

Zydus Wellness Transcript: Q2 26/27

Q2 sales and EBITDA rose sharply, with domestic categories and brands delivering broad growth. Management expects continued double-digit Comfort Click growth and margin improvement, while inflation and seasonal volatility remain key uncertainties.

7 days ago - Transcripts

Zydus Wellness Quarterly report: Q2 2027

Zydus Wellness has published its Q2 2027 quarterly earnings report on November 3, 2026.

7 days ago - Filings

Zydus Wellness Slides: Q2 2027

Zydus Wellness has posted slides in relation to its Q2 2027 quarterly earnings report, which was published on November 3, 2026.

7 days ago - Filings

FSSAI issues notices to Nestle, Zydus Wellness over ‘misleading claims’ in Complan, Lactogen, Nan

The Food Safety and Standards Authority of India has issued notices regarding misleading claims by Nestle and Zydus Wellness. Nestle's Lactogen Pro 1 Powder and Nan Excella Pro Stage 1 have claims nee...

20 days ago - The Times of India

Nestle, Zydus, Abbott face India scrutiny over claims on children's products

India's food safety regulator issued notices to Nestle India , Zydus Wellness , Abbott Healthcare and others on Wednesday over promotional claims involving products for infants and children that it sa...

20 days ago - Reuters

Zydus Wellness Transcript: Q1 26/27

Q1 FY 2027 delivered strong sales and EBITDA growth, driven by premiumization, innovation, and robust international performance, despite weather-related challenges in seasonal brands. Comfort Click and digital channels were key growth drivers, with margin expansion and stable financing costs.

3 months ago - Transcripts

Zydus Wellness Quarterly report: Q1 2027

Zydus Wellness has published its Q1 2027 quarterly earnings report on August 4, 2026.

3 months ago - Filings

Zydus Wellness Slides: Q1 2027

Zydus Wellness has posted slides in relation to its Q1 2027 quarterly earnings report, which was published on August 4, 2026.

3 months ago - Filings

Zydus Wellness incorporates new subsidiary in Dubai with AED 300,000 capital

Zydus Wellness Limited has announced the incorporation of a new step-down wholly owned subsidiary, Zydus Wellness General Trading DWC-LLC (ZWGTL), in Dubai, UAE. The Certificate of Incorporation was r...